Non-Invasive Prenatal Testing Market will reach USD 13.6 Billion by 2027.

“Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, NGS, Ultrasound, Microarray, PCR), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Sex Chromosome Abnormalities), & End User - Forecast to 2027”

Pune, India - January 14, 2020 /MarketersMedia/ —

Growing incidence of genetic disorders and advancements in genome sequencing technologies has made prenatal screening procedure imperative to provide tailored diagnosis of fetal genetic disorders. Meticulous Research® in its latest publication on Non-Invasive Prenatal Testing Market states that the global non-invasive prenatal testing market will increase at a CAGR of 17.1% from 2019 to 2027 to exceed $13.6 billion by 2027.

The growth in the non-invasive prenatal testing market is mainly attributed to shifting trend towards childbirth at an advanced maternal age, rising occurrences of chromosomal abnormalities, and improvements in reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market potential in the emerging economies offer significant growth opportunities for the players operating in non-invasive prenatal testing market.

To provide efficient analysis, Meticulous Research® has segmented this market on the basis of Product & Solution (Consumables, Systems, Software, Service), Method (Ultrasound Screening, Cell Free DNA Screening), Application (Trisomy, Microdeletions, Sex Chromosomal Abnormalities), End-user (Diagnostic Laboratories, Hospitals, Academic & Research Institutes) and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Wherein, geographically, North America commanded the largest share of the global non-invasive prenatal testing market followed by Europe. The major share of North America is mainly attributed to the high diagnostic and treatment rate of trisomy disorders in the region and improving reimbursement scenario for NIPT services in the U.S.

In terms of product, the consumables segment accounted for the largest share of the NIPT products market in 2018. The large share of this segment is mainly attributed to the increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.

In terms of method, the ultrasound screening methods commanded the largest share of the global non-invasive prenatal testing market in 2018; due to growing technological advancements like use of 3D and 4D ultrasound imaging, innovations leading to miniaturization of devices, and increasing awareness about the advantages offered by these devices.

On the basis of application, trisomy detection segment accounted for the largest share of this market in 2018 due to rising incidences of trisomies due to increasing maternal age, higher accuracy and lower cost of NIPT methods to detect trisomy as compared to other invasive methods.

On the basis of end users, diagnostic laboratories accounted for the largest share of NIPT market, in 2018; as majority of the tests are performed in third-party clinical labs. Availability of trained technicians and we-equipped infrastructure are some of the reasons for larger share of this segment in the global non-invasive prenatal testing market.

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Igenomix S.L (Spain), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.).

Click the link to Purchase Report NOW!! https://www.meticulousresearch.com/buy_now.php?pformat=369&vformat=1094

Market Study based on –

1.Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders

2.Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Foetus
4.2.3. Availability of Reimbursement Scenario for NIPT
4.2.4. Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products
4.3. Restraint
4.3.1. High Cost of the Non-invasive Prenatal Screening Techniques
4.4. Opportunities
4.4.1. Rising Awareness Regarding NIPT
4.4.2. Untapped Emergence of New Market
4.5. Challenges
4.5.1. Reliability of the Tests

5. Global NIPT Market, by Product and Solution
5.1. Introduction
5.2. Consumables
5.3. Systems
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Microarrays
5.3.4. Polymerase Chain Reaction Instruments
5.4. Software
5.5. Services

6. Global NIPT Market, by Method
6.1. Introduction
6.2. Ultrasound Screening
6.3. Cell-Free DNA Screening

Fill the Pre-Order Enquiry form for the report - https://www.meticulousresearch.com/enquire-before-buying/cp_id=5068

7. Global NIPT Market, by Application
7.1. Introduction
7.2. Trisomy
7.3. Microdeletion Syndrome
7.4. Sex Chromosome Abnormalities
7.5. Other Applications

8. Global NIPT Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals
8.4. Academic & Research Institutes

9. Global NIPT Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. RoE
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. RoAPAC
9.5. Latin America
9.6. Middle East & Africa

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis, By Company (2018)

11. Company Profiles
11.1. Illumina, Inc.
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Thermo Fisher Scientific Inc.
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. PerkinElmer, Inc.
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.3.4. Strategic Developments
11.4. Agilent Technologies, Inc.
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Beijing Genomics Institute
11.5.1. Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.6. Eurofins LifeCodexx AG
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.6.4. Strategic Developments
11.7. NATERA, INC.
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.7.4. Strategic Developments
11.8. IGENOMIX.
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Laboratory Corporation of America Holdings
11.9.1. Business Overview
11.9.2. Financial Overview
11.9.3. Product Portfolio
11.9.4. Strategic Developments
11.10. F. Hoffman-La Roche Ltd.
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. Yourgene Health
11.11.1. Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
11.12. GE Healthcare
11.12.1. Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Strategic Developments

12. Appendix
12.1. Questionnaire
12.2. Available Customization

👉 ……..Continue to read detail research on NIPT market then Download Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5068https://www.meticulousresearch.com/download-sample-report/cp_id=5068

🔹More Trending Reports by Meticulous Market Research:

Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025 @ https://www.meticulousresearch.com/product/digital-diabetes-market-4946/

Next Generation Sequencing Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User – Global Forecast to 2025 @ https://www.meticulousresearch.com/product/next-generation-sequencing-ngs-services-market-5041/

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91 744-7780008
Website: https://www.meticulousresearch.com/product/non-invasive-prenatal-testing-market-5068/

Source URL: https://marketersmedia.com/non-invasive-prenatal-testing-market-will-reach-usd-13-6-billion-by-2027/88942667

Source: MarketersMedia

Release ID: 88942667

Latest News

Putin engineers shakeup that could keep him in power longer

Jul 9, 2020

MOSCOW — President Vladimir Putin engineered a surprise shakeup of Russia's leadership Wednesday, proposing changes to the constitution that could keep him in power well past the end of his term in 2024. Prime Minister Dmitry Medvedev resigned his post after Putin announced the proposed constitutional amendments. Putin kept his longtime ally in the Kremlin's leadership structure, appointing him to the newly created post of deputy head of the presidential Security Council. The shakeup sent shock waves through Russia's political elites who were left pondering what Putin's intentions were and speculating about future Cabinet appointments. Putin’s proposed constitutional reforms, announced...

Sultan Qaboos bin Said, who modernized Oman, dies at 79

Jul 9, 2020

DUBAI, United Arab Emirates — Oman’s Sultan Qaboos bin Said, the Mideast's longest-ruling monarch who seized power in a 1970 palace coup and pulled his Arabian sultanate into modernity while carefully balancing diplomatic ties between adversaries Iran and the U.S., has died. He was 79. The British-educated, reclusive sultan reformed a nation that was home to only three schools and harsh laws banning electricity, radios, eyeglasses and even umbrellas when he took the throne. Under his reign, Oman became known as a welcoming tourist destination and a key Mideast interlocutor, helping the U.S. free captives in Iran and Yemen and...

On streets of Tehran, relief for now at no wider conflict

Jul 9, 2020

TEHRAN, Iran — Iranian newspapers proclaimed the country's attack on U.S. forces in Iraq to be "a dark night for Americans," and Washington's "first admission of failure in history." On the bustling streets of Tehran, however, there was relief Thursday that neither side appeared primed for war. “War is not something like the ‘Call of Duty’ game," said Dara Shojaei, a 23-year-old architecture student. “It's not a game you can play to win. There's no winner.” But with the relief came some mixed feelings about how far Iran should go to avenge the killing of Revolutionary Guard Gen. Qassem Soleiman,...

Stocks rise as China confirms trade deal signing next week

Jul 9, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

Soleimani, a general who became Iran icon by targeting US

Jul 9, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com